Document is current
Any future updates will be listed below
-
Authors
Dagotto, Gabriel
Colarusso, Alessandro
Patio, Robert C
Li, David
Anioke, Tochi
Giffin, Victoria
Guan, Ruoran
Anand, Trisha
Mbiwan, Esther
Aid, Malika
Barouch, Dan https://orcid.org/0000-0001-5127-4659
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03219450 at ClinicalTrials.govnct01970358 at ClinicalTrials.govDocuments that mention this clinical trial
Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8<sup>+</sup> T cell control of tumor challenge in mice
https://doi.org/10.1136/jitc-2024-009644
nct02600949 at ClinicalTrials.govDocuments that mention this clinical trial
327 Development and validation of a neoantigen-specific T cell gene signature to identify antitumor T cells in lung cancer and melanoma
https://doi.org/10.1136/jitc-2021-sitc2021.327
Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8<sup>+</sup> T cell control of tumor challenge in mice
https://doi.org/10.1136/jitc-2024-009644
665 Transcriptional landscape of tumor-reactive TIL in lung cancer and melanoma
https://doi.org/10.1136/jitc-2021-sitc2021.665
Documents that mention this clinical trial
Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer
https://doi.org/10.1136/jitc-2020-001100
Adenoviral-vectored neoantigen vaccine augments hyperexpanded CD8<sup>+</sup> T cell control of tumor challenge in mice
https://doi.org/10.1136/jitc-2024-009644
-
Funding
Funding for this research was provided by:
Ragon Institute of MGH, MIT and Harvard (N/A)
- License Information
